2005-06-01

Novartis receives European Commission approval to acquire Hexal AG, further step towards creating world leader in Generics

Novartis announced today that it has received approval from the European Commission to acquire the privately-held generic pharmaceutical company Hexal AG of Germany. The acquisition is expected to be completed in early June. Press Release

Tillbaka till nyheter